B. Jackson
Impact in
- Nephrology top 2%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
Papers in
-
- Renin-Angiotensin System Studies 12
- Co-authors
- C. I. JohnstonBruno FabrisY-L. ChanAlan J. ThompsonClarkson ArSeymour AeColin I. JohnstonHiroshi Yamada
- Journals
- Clinical and Experimental Pharmacology and Physiology (12 papers)Journal of Cardiovascular Pharmacology (6 papers)Hypertension (3 papers)The Medical Journal of Australia (3 papers)Drugs (2 papers)
- Partner nations
- AustraliaUnited StatesSlovakia
In The Last Decade
B. Jackson
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Nephrology 328
- Cardiology and Cardiovascular Medicine 664
- Endocrinology, Diabetes and Metabolism 275
- Pulmonary and Respiratory Medicine 312
- Rheumatology 126
Countries citing papers authored by B. Jackson
This map shows the geographic impact of B. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Jackson more than expected).
Fields of papers citing papers by B. Jackson
This network shows the impact of papers produced by B. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Jackson. The network helps show where B. Jackson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Apparent efficacy and safety of low dose naltrexone in Australian patients with active Crohn's disease | 2013 | 1 |
| 2 | 2010 | 85 | |
| 3 | 2006 | 14 | |
| 4 | 2005 | 26 | |
| 5 | 2003 | 67 | |
| 6 | 1997 | 20 | |
| 7 | 1995 | 5 | |
| 8 | 1994 | 6 | |
| 9 | 1992 | 21 | |
| 10 | 1992 | 21 | |
| 11 | 1991 | 17 | |
| 12 | 1989 | 2 | |
| 13 | 1988 | 3 | |
| 14 | 1988 | 27 | |
| 15 | 1988 | 12 | |
| 16 | 1988 | 17 | |
| 17 | 1987 | 8 | |
| 18 | 1987 | 1 | |
| 19 | 1987 | 6 | |
| 20 | 1985 | 4 |
About B. Jackson
B. Jackson is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Pharmacology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (12 papers), Protein Hydrolysis and Bioactive Peptides (11 papers), Hormonal Regulation and Hypertension (7 papers), Vitamin K Research Studies (6 papers), Electrolyte and hormonal disorders (6 papers), Neuropeptides and Animal Physiology (6 papers), Renal and Vascular Pathologies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Nephrology (328 citations), Cardiology and Cardiovascular Medicine (664 citations), Endocrinology, Diabetes and Metabolism (275 citations), Pulmonary and Respiratory Medicine (312 citations) and Rheumatology (126 citations). B. Jackson has collaborated with scholars based in Australia, United States and Slovakia. Frequent co-authors include C. I. Johnston, Bruno Fabris, C. I. Johnston, Y-L. Chan, Alan J. Thompson, Clarkson Ar, Seymour Ae, Colin I. Johnston, Hiroshi Yamada and F. A. O. Mendelsohn. Their work appears in journals such as Clinical and Experimental Pharmacology and Physiology, Journal of Cardiovascular Pharmacology, Hypertension, The Medical Journal of Australia and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.